← Leaderboards
Andrew M Tager
Massachusetts General Hospital
$6,891,119
Attributed
$7,740,605
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2008–19$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,740,605 · 8
By mechanism
R01$4,180,499 · 4
U19$2,127,141 · 1
P30$755,743 · 1
K08$519,236 · 1
R03$157,986 · 1
Top collaborators
- Peter D Caravan1 shared
- Michael Lanuti1 shared
- Jason R. Mccarthy1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Andrew D Luster$52,151,359
- Flavia V Castelino$694,134
- Alejandro Benjamin Balazs$9,513,558
- Jennifer Hodge Dufour$118,804
- Petra Simic$865,500
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseResearch StudyBleomycinPathogenesisTissuesGenerationsHamman-Rich SyndromePulmonary FibrosisLungFibrosisIn VivoDesignSiteNovel TherapeuticsMorbidity - Disease RateMediator Of Activation ProteinMemberInsightLung InjuryPathway InteractionsGenesDiagnosisLung DevelopmentMortality Vital Statistics
Grant awards (23)
CORE B: Animal and Laboratory Core$436,026
U19 · FY2019 · HL · contact PI
CORE B: Animal and Laboratory Core$563,705
U19 · FY2018 · HL · contact PI
Humanized Mouse Core$168,320
P30 · FY2018 · AI · contact PI
PET Imaging of Pulmonary Fibrosis$769,321
R01 · FY2016 · HL
Targeting Cell-specific Functions of the Rho Kinase Pathway in Pulmonary Fibrosis$673,211
R01 · FY2016 · HL · contact PI
CORE B: Animal and Laboratory Core$563,705
U19 · FY2016 · HL · contact PI
Humanized Mouse Core$194,881
P30 · FY2016 · AI · contact PI
CORE B: Animal and Laboratory Core$563,705
U19 · FY2015 · HL · contact PI
Humanized Mouse Core$196,644
P30 · FY2015 · AI · contact PI
Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis$144,494
R01 · FY2015 · HL · contact PI
Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis$412,324
R01 · FY2014 · HL · contact PI
Humanized Mouse Core$195,898
P30 · FY2014 · AI · contact PI
Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis$400,543
R01 · FY2013 · HL · contact PI
Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis$421,316
R01 · FY2012 · HL · contact PI
Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis$437,172
R01 · FY2011 · HL · contact PI
The LPA Pathway in Lung Fibrosis: Novel Mediators and New Therapeutic Targets$456,242
R01 · FY2010 · HL · contact PI
The LPA Pathway in Lung Fibrosis: Novel Mediators and New Therapeutic Targets$465,876
R01 · FY2009 · HL · contact PI
LPA Pathway Genetic Variation and Expression Profile in IPF$70,069
R03 · FY2009 · HL · contact PI
LPA Pathway Genetic Variation and Expression Profile in IPF$87,917
R03 · FY2008 · HL · contact PI
T CELL AND EOSINOPHIL RECRUITMENT IN LUNG FIBROSIS$129,809
K08 · FY2003 · HL
T CELL AND EOSINOPHIL RECRUITMENT IN LUNG FIBROSIS$129,809
K08 · FY2002 · HL
T CELL AND EOSINOPHIL RECRUITMENT IN LUNG FIBROSIS$129,809
K08 · FY2001 · HL
T CELL AND EOSINOPHIL RECRUITMENT IN LUNG FIBROSIS$129,809
K08 · FY2000 · HL